6 assets in Generalized Epilepsy

Therapeutic assets addressing Generalized Epilepsy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cenobamate Generalized Epilepsy	Ono Pharmaceutical Co., Ltd.	P3	BB (64)
Opakalim Generalized Epilepsy	Biohaven Therapeutics Ltd.	P2/3	B (57)
Npt 2042 Generalized Epilepsy	NeuroPro Therapeutics, Inc.	P2	CCC (53)
Prax-628 Generalized Epilepsy	Praxis Precision Medicines	P2	NR ()
Vormatrogine Generalized Epilepsy	Praxis Precision Medicines	P3	NR ()